International Immunology, Vol 10, 1131-1138, Copyright © 1998 by Oxford University Press
P Wu and L Claflin
The distribution of somatic hypermutations around the rearranged V(D)J in
antigen-selected B cells is asymmetrical. At the 5' end of the gene a high
frequency of mutations does not occur until approximately 200 bp downstream
of the V gene promoter in the leader intron. This finding seems
inconsistent with recently proposed, transcription-coupled models of
hypermutation. Here we describe studies on extensively mutated copies of a
kappa light chain transgene which appear to exist as passenger genes for a
significant portion of their mutational history. These transgenes contain
between one and four in-frame stop codons, and have a ratio of replacement
to silent mutations in framework regions that is near random; the ratio in
their functional counterparts is clearly non-random. When non-functional
passenger and functional transgenes are compared, the patterns of mutation
in the leader intron are not significantly different; the frequency 3' is
greater in the passenger transgenes. This result indicates that the low
level mutational activity immediately 3' of the promoter followed by rapid
rise in activity is an intrinsic feature of the mutational process. One
inference from this finding is that there is a structural feature in V
region DNA or one induced during transcription which is critical to a
functioning mutator.
ARTICLES
Promoter-associated displacement of hypermutations
Department of Microbiology and Immunology, The University of Michigan Medical School, Ann Arbor 48109-0620, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. M. Shen, A. Tanaka, G. Bozek, D. Nicolae, and U. Storb Somatic Hypermutation and Class Switch Recombination in Msh6-/-Ung-/- Double-Knockout Mice J. Immunol., October 15, 2006; 177(8): 5386 - 5392. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Xue, C. Rada, and M. S. Neuberger The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice J. Exp. Med., September 4, 2006; 203(9): 2085 - 2094. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Longerich, A. Tanaka, G. Bozek, D. Nicolae, and U. Storb The very 5' end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions J. Exp. Med., November 21, 2005; 202(10): 1443 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Shapiro, K. Aviszus, J. Murphy, and L. J. Wysocki Evolution of Ig DNA Sequence to Target Specific Base Positions Within Codons for Somatic Hypermutation J. Immunol., March 1, 2002; 168(5): 2302 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Shen, A. Peters, D. Kao, and U. Storb The 3' Ig{{kappa}} enhancer contains RNA polymerase II promoters: implications for endogenous and transgenic {{kappa}} gene expression Int. Immunol., May 1, 2001; 13(5): 665 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oprea, L. G. Cowell, and T. B. Kepler The Targeting of Somatic Hypermutation Closely Resembles That of Meiotic Mutation J. Immunol., January 15, 2001; 166(2): 892 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Cowell and T. B. Kepler The Nucleotide-Replacement Spectrum Under Somatic Hypermutation Exhibits Microsequence Dependence That Is Strand-Symmetric and Distinct from That Under Germline Mutation J. Immunol., February 15, 2000; 164(4): 1971 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yi, P. Wu, K. W. Trevorrow, L. Claflin, and W. T. Garrard Evidence That the Ig{kappa} Gene MAR Regulates the Probability of Premature V-J Joining and Somatic Hypermutation J. Immunol., May 15, 1999; 162(10): 6029 - 6039. [Abstract] [Full Text] [PDF] |
||||


